Azoulay, E., Lemiale, V., Mokart, D., Nseir, S., Argaud, L., Pène, F., . . . Demoule, A. (2018). Effect of High-Flow Nasal Oxygen vs Standard Oxygen on 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial. JAMA.
Chicago ZitierstilAzoulay, Elie, et al. "Effect of High-Flow Nasal Oxygen Vs Standard Oxygen On 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial." JAMA 2018.
MLA ZitierstilAzoulay, Elie, et al. "Effect of High-Flow Nasal Oxygen Vs Standard Oxygen On 28-Day Mortality in Immunocompromised Patients With Acute Respiratory Failure: The HIGH Randomized Clinical Trial." JAMA 2018.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.